RecruitingPhase 4NCT06354582

Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia

Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia : A Randomized Controlled Trial


Sponsor

Kunyue Li

Enrollment

400 participants

Start Date

Apr 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to explore the effect of intravenous vitamin C infusion on intrapartum fever after epidural labor analgesia, to reduce the impact of intrapartum fever on maternal and infant, improve maternal and infant outcomes, and provide a reference for clinical preventive medication.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 35 Years

Inclusion Criteria1

  • single-fetus, head position, and full-term vaginal delivery receiving epidural labor analgesia.

Exclusion Criteria1

  • have a fever before epidural analgesia, acute infection on admission, incomplete baseline data, fatal fetal malformations or comorbidities, duration from admission to delivery of more than 72 hours or less than 3 hours, or an American Society of Anesthesiologists (ASA) classification of ≥ Ⅲ.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVitamin C Injection

Drug Specification: 5ml: 1g. Method: parturients in each group will be intravenously injected with corresponding dose after receiving epidural labor analgesia.

OTHERNormal saline

The placebo comparator will receive normal saline with the same volume and be administered after the induction of epidural labor anesthesia.


Locations(1)

Third Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06354582


Related Trials